Belsomra wakes up a tired category
28.09.2015A few years ago, The New Yorker ran a fascinating story about the FDA and the long, nightmarish process Merck underwent to get approval for a new class of anti-insomnia drugs. The article appeared in December 2013 and this month, the first commercial promoting the medication arrived…with a whisper. Unlike most sleeping pills, which knock…